tris(2-carboxyethyl)phosphine and Fatty Liver

tris(2-carboxyethyl)phosphine has been researched along with Fatty Liver in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chen, X; Gu, N; Oh, Y; Wei, X; Yang, D; Zhang, Z; Zhu, R	1

Other Studies

1 other study(ies) available for tris(2-carboxyethyl)phosphine and Fatty Liver

Article	Year
Tris (2-chloroethyl) phosphate (TCEP) induces obesity and hepatic steatosis via FXR-mediated lipid accumulation in mice: Long-term exposure as a potential risk for metabolic diseases. Chemico-biological interactions, 2022, Aug-25, Volume: 363 Topics: Animals; Bile Acids and Salts; Fatty Liver; Flame Retardants; Humans; Lipids; Metabolic Diseases; Mice; Mice, Inbred ICR; Obesity; Organophosphates; Phosphates; Phosphines	2022

Article

Year

Tris (2-chloroethyl) phosphate (TCEP) induces obesity and hepatic steatosis via FXR-mediated lipid accumulation in mice: Long-term exposure as a potential risk for metabolic diseases.

Chemico-biological interactions, 2022, Aug-25, Volume: 363

Topics: Animals; Bile Acids and Salts; Fatty Liver; Flame Retardants; Humans; Lipids; Metabolic Diseases; Mice; Mice, Inbred ICR; Obesity; Organophosphates; Phosphates; Phosphines

2022